Skin Antiseptic Products Market Report 2024

This Skin Antiseptic Products market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The skin antiseptic products market size has grown strongly in recent years. It will grow from $5.22 billion in 2023 to $5.71 billion in 2024 at a compound annual growth rate (CAGR) of 9.4%. The increase observed during the historical period can be linked to the rise in surgical procedures, healthcare-associated infections (HAIs), the expanding elderly population, the growing incidence of chronic diseases, and advancements in healthcare infrastructure.

The skin antiseptic products market size is expected to see strong growth in the next few years. It will grow to $8.22 billion in 2028 at a compound annual growth rate (CAGR) of 9.5%. The anticipated growth during the forecast period can be ascribed to the increasing frequency of infectious diseases, the expansion of healthcare services, heightened awareness of personal hygiene, a growing demand for home healthcare, and supportive regulations. Key trends expected in this period include advancements in smart antiseptic dispensers, the adoption of sustainable formulations, progress in nanotechnology, a rise in wearable antiseptic devices, and developments in solutions for antimicrobial resistance.

The growth of the skin antiseptic products market is anticipated to increase with the rising number of surgeries. Surgery involves the manual manipulation, removal, or repair of tissues or organs through incisions or other techniques to diagnose, treat, or improve a patient’s health. Advances in laparoscopic and robotic surgery have made procedures less invasive, resulting in shorter recovery times and encouraging more people to undergo surgical treatments. Skin antiseptic products play a crucial role in preoperative procedures by managing infection risks, adhering to hygiene standards, and ensuring patient safety. For example, the British Association of Aesthetic Plastic Surgeons reported that there were 31,057 cosmetic surgeries in the UK in 2022, a significant 102% increase from the previous year. This increase in surgeries is driving the demand for skin antiseptic products.

Key companies in the skin antiseptic products market are focusing on developing solutions for patient preoperative skin preparation to enhance infection control and improve surgical outcomes. These preparations are designed to clean and disinfect the skin before surgery by eliminating or inhibiting bacteria, viruses, and fungi. For instance, in April 2023, 3M Health Care Company introduced the 3M SoluPrep S Sterile Antiseptic Solution, which combines chlorhexidine gluconate (2% w/v) and isopropyl alcohol (70% v/v). This solution offers rapid, broad-spectrum antimicrobial activity and remains effective for at least 96 hours after application. It features a Brite Green tint for better visibility on various skin tones and an applicator that ensures extensive coverage with minimal dripping while enhancing the adherence of incise-drapes.

In September 2022, Schülke & Mayr GmbH, a Germany-based provider of infection prevention and hygiene solutions, acquired Vesismin Health. The acquisition, for an undisclosed amount, is intended to boost Schülke’s presence in Southern Europe, particularly in Spain and France, and to create synergies in research and development as well as sourcing. This move will help Vesismin Health enhance its innovative reputation and strengthen its market position in Spain and internationally. Vesismin Health, located in Spain, manufactures skin antiseptic products, including pre-surgical antiseptic cleaning solutions.

Major companies operating in the skin antiseptic products market are Cardinal Health Inc., Johnson And Johnson Services Inc., Kimberly-Clark Corporation, Becton Dickinson And Company, Stryker Corporation, EcoLab Inc., Medline Industries LP., B.Braun Melsungen AG, 3M Health Care Ltd., Cintas Corporation, Smith And Nephew Plc, Coloplast A/S, Convatec Group plc, Mölnlycke Health Care AB, Gojo Industries Inc., Schülke And Mayr GmbH, Purell, Dukal LLC, PDI International, Cleanwell, Medique, ‎GOXNOR.

North America was the largest region in the skin antiseptic products market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the skin antiseptic products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the skin antiseptic products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Skin antiseptic products are used to disinfect the skin and reduce microbial presence before medical procedures to prevent infections. These products work by lowering the number of harmful bacteria, viruses, and fungi on the skin.

The main types of skin antiseptic products include solutions, swab sticks, and wipes. Solutions are liquid antiseptics applied directly to the skin or used in medical settings for infection control. They come in various formulations, such as alcohols, chlorhexidine, iodine, and octenidine, and are used for purposes like surgeries and injections. These products are employed across various settings, including hospitals, outpatient facilities, home care, research, and manufacturing.

The skin antiseptic products market research report is one of a series of new reports that provides skin antiseptic products market statistics, including the skin antiseptic products industry global market size, regional shares, competitors with the skin antiseptic products market share, detailed skin antiseptic products market segments, market trends, and opportunities, and any further data you may need to thrive in the skin antiseptic products industry. These skin antiseptic products market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The skin antiseptic products market consists of sales of products such as benzalkonium chloride, hydrogen peroxide, and povidone-iodine solutions. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.